avelumab
merck,pfizer
[]
 fellow &amp;team and presenting iconic trial data of perioperative flot + avelumab in early stage oesophago-gastric ca at asco #gi23. adding immunotherapy did not increase pathologic cr but tumour regression better in pdl1+ tumours, 
Academic GI Cancer Centre in the City of London. Delivering evidence-based treatments and clinical trials to patients. Informing and education patients and HCPs